T
AZN icon

Tidemark’s AstraZeneca AZN Stock Holding History

Tidemark’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.12K Hold
27
– – ﹤0.01% 593
2026
Q1 		$5.33K Sell
27
-1
-4% -$193 ﹤0.01% 546
2025
Q4 		$5.06K Sell
28
-4
-13% -$702 ﹤0.01% 501
2025
Q3 		$4.91K Hold
32
– – ﹤0.01% 530
2025
Q2 		$4.47K Hold
32
– – ﹤0.01% 536
2025
Q1 		$4.7K Hold
32
– – ﹤0.01% 534
2024
Q4 		$4.19K Hold
32
– – ﹤0.01% 529
2024
Q3 		$4.99K Hold
32
– – ﹤0.01% 491
2024
Q2 		$4.99K Hold
32
– – ﹤0.01% 471
2024
Q1 		$4.34K Hold
32
– – ﹤0.01% 528
2023
Q4 		$4.31K Buy
+32
New +$4.16K ﹤0.01% 523

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Tidemark's AZN Position: Q2 2026 in Review

Tidemark held its AstraZeneca (AZN) position steady in Q2 2026 at 27 shares worth $5.12K. The position accounts for ﹤0.01% of the portfolio, ranked #593.

Tidemark first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.33K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Tidemark held 27 shares of AstraZeneca worth $5.12K as of Q2 2026.
  • Tidemark left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #593 holding.
  • Tidemark first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
  • Tidemark's AstraZeneca position peaked at $5.33K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.